Latest Stimuvax Stories
DARMSTADT, Germany, September 12, 2014 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, announced today that its biopharmaceutical division will discontinue the clinical
ROCKLAND, Massachusetts, April 7, 2014 /PRNewswire/ -- - First patient dosed in tecemotide Phase III trial; study recruiting
Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of
ONCOTHYREON TO HOLD TELECONFERENCE AT 5:00 PM EDT SEATTLE, March 23 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that Merck Serono, a division of Merck KGaA of Darmstadt, Germany, and its U.S.
SEATTLE, June 22 /PRNewswire-FirstCall/ - Oncothyreon Inc.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.